Position in GILD
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$6,677,321
-$731,309 QoQ
Shares Held
52,852
-0.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#516
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Oliver Luxxe Assets LLC holds $24,335,082 across 7 Drug Manufacturers - General names. GILD ranks #3 (27.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
45,272 | $8,584,476 | |
| 2 | ABBV |
AbbVie Inc.
|
31,485 | $7,922,885 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
52,852 | $6,677,321 | |
| 4 | PFE |
Pfizer Inc
|
18,762 | $451,788 | |
| 5 | JNJ |
Johnson & Johnson
|
1,059 | $268,954 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,681 | $216,008 | |
| 7 | AMGN |
Amgen Inc
|
590 | $213,650 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,677,321 | 52,852 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $7,408,630 | 53,158 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $8,197,559 | 66,788 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $7,330,884 | 66,044 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $6,925,494 | 62,465 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $6,645,573 | 59,309 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,463,133 | 48,318 | Shares | Sole | 2025-01-06 | |
| No filing history on record for this holder in this stock. | ||||||